ExploreWatchlistsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. EBITDA margin (%)

HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Feb 28, 202516.1+24.64%
Feb 29, 202412.9+0.00%
Feb 28, 202312.9+13.50%
Feb 28, 202211.4-11.78%
Feb 28, 202112.9-32.68%
Feb 29, 202019.1-2.07%
Feb 28, 201919.5-10.69%
Feb 28, 201821.9-2.50%
Feb 28, 201722.4+3.16%
Feb 29, 201621.8+25.38%
Feb 28, 201517.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat